Dagmar Schlenzig
Impact in
- Physiology top 5%
- Alzheimer's disease research and treatments
-
- Diabetes Treatment and Management
Papers in
-
- Protease and Inhibitor Mechanisms 8
-
- Alzheimer's disease research and treatments 7
- Co-authors
- Hans‐Ulrich Demuth (8 shared papers)Hans‐Ulrich Demuth (7 shared papers)Christopher H.S. McIntosh (2 shared papers)Raymond A. Pederson (2 shared papers)Stephan Schilling (3 shared papers)Susanne Manhart (3 shared papers)Robert P. Pauly (1 shared paper)Martin Kleinschmidt (2 shared papers)
In The Last Decade
Dagmar Schlenzig
25 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 70
- Physiology 550
- Endocrinology, Diabetes and Metabolism 255
- Cancer Research 69
- Cellular and Molecular Neuroscience 76
- Pharmacology 63
Countries citing papers authored by Dagmar Schlenzig
This map shows the geographic impact of Dagmar Schlenzig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dagmar Schlenzig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dagmar Schlenzig more than expected).
Fields of papers citing papers by Dagmar Schlenzig
This network shows the impact of papers produced by Dagmar Schlenzig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dagmar Schlenzig. The network helps show where Dagmar Schlenzig may publish in the future.
Co-authors
The 25 scholars most cited alongside Dagmar Schlenzig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 314 | |
| 2 | 1998 | 244 | |
| 3 | 2007 | 209 | |
| 4 | 2009 | 173 | |
| 5 | 2012 | 77 | |
| 6 | 2001 | 63 | |
| 7 | 2010 | 45 | |
| 8 | 2016 | 44 | |
| 9 | 2015 | 29 | |
| 10 | 1993 | 25 | |
| 11 | 2017 | 22 | |
| 12 | 2018 | 21 | |
| 13 | 2016 | 18 | |
| 14 | 2017 | 16 | |
| 15 | 2018 | 13 | |
| 16 | 2015 | 11 | |
| 17 | 2020 | 11 | |
| 18 | 2021 | 10 | |
| 19 | 2018 | 9 | |
| 20 | 2022 | 9 |
About Dagmar Schlenzig
Dagmar Schlenzig is a scholar working on Cancer Research, Physiology, Oncology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism, having authored 25 papers that have together received 1.4k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (8 papers), Alzheimer's disease research and treatments (7 papers), Peptidase Inhibition and Analysis (4 papers), Fungal and yeast genetics research (2 papers), Diabetes Treatment and Management (2 papers), Receptor Mechanisms and Signaling (1 paper), Pancreatic function and diabetes (1 paper) and Genetic Neurodegenerative Diseases (1 paper). The work is most often cited by research in Physiology (550 citations), Endocrinology, Diabetes and Metabolism (255 citations), Cancer Research (69 citations), Cellular and Molecular Neuroscience (76 citations) and Pharmacology (63 citations). Dagmar Schlenzig has collaborated with scholars based in Germany, Canada and Japan. Frequent co-authors include Hans‐Ulrich Demuth, Hans‐Ulrich Demuth, Christopher H.S. McIntosh, Raymond A. Pederson, Stephan Schilling, Susanne Manhart, Robert P. Pauly, Martin Kleinschmidt, Jens‐Ulrich Rahfeld and Holger Cynis. Their work appears in journals such as Journal of Neurochemistry, ChemMedChem, Bioorganic & Medicinal Chemistry, Nature Medicine and Journal of Alzheimer s Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.